| Clearview Nursing Center | |
| 430 Salcedo Road, Po Box 707, Sikeston, Missouri 63801 | |
| (573) 471-2565 | |
| Name | Clearview Nursing Center |
|---|---|
| Location | 430 Salcedo Road, Po Box 707, Sikeston, Missouri |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 90 |
| Occupancy Rate | 30.22% |
| Medicare ID (CCN) | 265614 |
| Legal Business Name | N & R Of Sikeston At Clearview Inc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1154317535 |
| Organization Name | N & R OF SIKESTON AT CLEARVIEW INC |
| Doing Business As | CLEARVIEW NURSING CENTER |
| Address | 430 W Salcedo Rd, Sikeston, MO 63801 |
| Phone Number | 573-471-2565 |
News Archive
Folding your laundry or doing the dishes might not be the most enjoyable parts of your day. But simple activities like these may help prolong your life, according to the findings of a new study in older women led by the University at Buffalo.
Gloucester Pharmaceuticals will discuss the New Drug Application for romidepsin to treat patients with cutaneous T-cell lymphoma (CTCL) at the Oncologic Drugs Advisory Committee (ODAC) meeting on September 2, 2009.
Merck today provided the following statement on the changes to the clinical studies for vorapaxar, one of the Company's investigational cardiovascular medicines, following an announcement from the two academic centers leading the studies of vorapaxar.
The Swanson School of Engineering at the University of Pittsburgh has received a $3.54 million grant from the Wallace H. Coulter Foundation.
› Verified 6 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Folding your laundry or doing the dishes might not be the most enjoyable parts of your day. But simple activities like these may help prolong your life, according to the findings of a new study in older women led by the University at Buffalo.
Gloucester Pharmaceuticals will discuss the New Drug Application for romidepsin to treat patients with cutaneous T-cell lymphoma (CTCL) at the Oncologic Drugs Advisory Committee (ODAC) meeting on September 2, 2009.
Merck today provided the following statement on the changes to the clinical studies for vorapaxar, one of the Company's investigational cardiovascular medicines, following an announcement from the two academic centers leading the studies of vorapaxar.
The Swanson School of Engineering at the University of Pittsburgh has received a $3.54 million grant from the Wallace H. Coulter Foundation.
› Verified 6 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 1.87 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 5.77 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 46.25 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.97 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 9.65 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 5.66 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 8.55 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 96.58 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 26.61 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 73.53 | 83.88 |